R
Roman Bystrianyk
Guest
http://www.healthsentinel.com/org_news.php?event=org_news_print_list_item&id=20
Roman Bystrianyk, "Coffee Consumption and the Link to Cardiovascular
Disease", Health Sentinel, February 1, 2005,
According to the Specialty Coffee Association of America, in 1999 there
were over 100 million coffee consumers in the United States spending an
approximate 9.2 billion in retail and 8.7 billion in the foodservice
sector each year on coffee. The National Coffee Association estimates
that among coffee drinkers the average consumption is over 3 cups of
coffee per day in the United States.
Inflammation is important to the development of cardiovascular disease
(CVD) and a study in the October issue of the American Journal of
Clinical Nutrition examines the effect of coffee on low-grade systemic
inflammation.
"Studies have suggested that low-grade systemic inflammation
participates in the pathophysiology of obesity, insulin resistance,
ischemic heart disease, metabolic syndrome X, and abnormal coagulation
process. An extensive body of scientific evidence also suggests that
dietary factors exert their influence largely through their effects on
blood pressure, lipids and lipoproteins, as well as on markers of
inflammation and coagulation. This evidence implies that dietary
intervention designed to reduce the inflammatory process could be of
benefit in reducing the risk of cardiovascular disease."
The authors examined a variety of inflammatory markers in over 3,000
men and women to determine the effect of coffee on systemic
inflammation. They found that those who consumed more than 200
milliliters per day of coffee, which is approximately 1 cup of coffee,
had significantly higher inflammatory markers. "All inflammatory
markers showed a linear dose-response relation with coffee consumption.
Compared with coffee nondrinking men, those men who consumed > 200 mL
coffee/d had an average 30% higher CRP [C-reactive Protein], 50% higher
IL-6 [Interleukin], 12% higher SAA [Serum Amyloid-A], and 28% higher
TNF-a [Tumor Necrosis Factor]."
The study showed that even moderate consumption of unfiltered coffee
increases the amounts of proinflammatory markers involved in ischemic
heart disease. Since caffeine could be the most frequently ingested
pharmacologically active substance globally the authors conclude that,
"evaluation of the effects of coffee consumption on various
cardiovascular markers should be of great importance from a public
health perspective."
SOURCE: American Journal of Clinical Nutrition, October 2004
Roman Bystrianyk, "Coffee Consumption and the Link to Cardiovascular
Disease", Health Sentinel, February 1, 2005,
According to the Specialty Coffee Association of America, in 1999 there
were over 100 million coffee consumers in the United States spending an
approximate 9.2 billion in retail and 8.7 billion in the foodservice
sector each year on coffee. The National Coffee Association estimates
that among coffee drinkers the average consumption is over 3 cups of
coffee per day in the United States.
Inflammation is important to the development of cardiovascular disease
(CVD) and a study in the October issue of the American Journal of
Clinical Nutrition examines the effect of coffee on low-grade systemic
inflammation.
"Studies have suggested that low-grade systemic inflammation
participates in the pathophysiology of obesity, insulin resistance,
ischemic heart disease, metabolic syndrome X, and abnormal coagulation
process. An extensive body of scientific evidence also suggests that
dietary factors exert their influence largely through their effects on
blood pressure, lipids and lipoproteins, as well as on markers of
inflammation and coagulation. This evidence implies that dietary
intervention designed to reduce the inflammatory process could be of
benefit in reducing the risk of cardiovascular disease."
The authors examined a variety of inflammatory markers in over 3,000
men and women to determine the effect of coffee on systemic
inflammation. They found that those who consumed more than 200
milliliters per day of coffee, which is approximately 1 cup of coffee,
had significantly higher inflammatory markers. "All inflammatory
markers showed a linear dose-response relation with coffee consumption.
Compared with coffee nondrinking men, those men who consumed > 200 mL
coffee/d had an average 30% higher CRP [C-reactive Protein], 50% higher
IL-6 [Interleukin], 12% higher SAA [Serum Amyloid-A], and 28% higher
TNF-a [Tumor Necrosis Factor]."
The study showed that even moderate consumption of unfiltered coffee
increases the amounts of proinflammatory markers involved in ischemic
heart disease. Since caffeine could be the most frequently ingested
pharmacologically active substance globally the authors conclude that,
"evaluation of the effects of coffee consumption on various
cardiovascular markers should be of great importance from a public
health perspective."
SOURCE: American Journal of Clinical Nutrition, October 2004